Brazil Threatens AIDS Patent

Brazil’s Ministry of Health has demanded that Abbott Laboratories cut the price of its AIDS drug Kaletra by 42%, threatening to break the company’s patent and produce generic versions of the drug if it does not comply. The Abbott Park, Illinois-based company has 10 days from the time it received Friday’s ruling to agree to reduce Kaletra’s price to $0.68 per pill from $1.17. If Brazil follows through on its threat, the move would mark the first time the country has adopted compulsory licensing — via BoingBoing